Airport Mpox Bust Stuns FBI

Two National Institutes of Health (NIH) scientists walked off a plane at Detroit Metro Airport carrying 113 vials of mpox virus — and lied to federal agents about it.

Story Snapshot

Two NIH-affiliated researchers face federal charges for smuggling deactivated mpox vials into the U.S. from the Republic of Congo and lying to authorities.
Federal Bureau of Investigation (FBI) agents found 113 vials in the scientists’ luggage; 17 of the 20 tested so far contained mpox material.
The researchers traveled from Brazzaville, Republic of Congo — where an active mpox outbreak was underway — and arrived at Detroit Metro Airport in January 2026.
The core legal fight is not about whether the virus was dangerous, but whether the scientists knowingly violated declaration rules and lied to federal agents.

What Federal Agents Found at Detroit Metro Airport

Vincent Munster, identified as chief of virus ecology at an NIH laboratory in Montana, and a research fellow named Kwe, arrived at Detroit Metro Airport in January 2026 after a trip to Brazzaville, Republic of Congo. Customs and Border Protection (CBP) officers flagged their luggage. When the FBI joined the inspection, agents discovered 113 vials. Of the first 20 tested, 17 came back positive for mpox, formerly known as monkeypox. Neither researcher had declared the biological materials to customs authorities. ^[1]

Federal prosecutors charged both scientists with conspiracy to smuggle monkeypox into the United States and with making false statements to federal law enforcement. ^[3] Those are not minor administrative violations. False statements to federal agents carry serious prison exposure, and smuggling charges compound that risk considerably. The Department of Justice did not treat this as a paperwork oversight — it treated it as a criminal conspiracy.

The Defense Argument and Why It Has Limits

The scientists’ side of the story centers on one word: deactivated. Their position, reflected in public statements, is that the mpox samples were inactivated virus — noninfectious, not transmissible to the public, and standard research material rather than a biohazard. ^[2] That framing is medically accurate as far as it goes. Deactivated viral material is not the same as live, replicating pathogen. Public health officials quoted in coverage reinforced that the general public faced no direct threat from the incident.

But the deactivated argument does not reach the charges the government actually filed. Prosecutors are not alleging the scientists tried to start an outbreak. They are alleging the scientists knew they were carrying regulated biological materials, failed to declare them at the border as required by law, and then lied about it when confronted by federal agents. ^[8] Whether a pathogen is infectious or not does not waive the legal obligation to declare it. The rules exist precisely because agents at the border cannot perform on-the-spot virology — they depend on travelers telling the truth.

Why Biosafety Declaration Rules Are Not Optional

The United States maintains a strict framework governing the import of biological agents and select agents, including any material derived from pathogens like mpox. Researchers working with such materials are expected to obtain proper permits, follow institutional biosafety protocols, and declare samples at the border without exception. ^[9] These rules are not bureaucratic formalities. They exist because the chain of custody for biological materials must be documented from collection to laboratory — particularly when samples originate in active outbreak zones like the Republic of Congo.

Two scientists at a U.S. government lab were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it during interviews with investigators at a Michigan airport, authorities said. https://t.co/gKdYYK1xHK

— ABC7 News (@abc7newsbayarea) June 3, 2026

The Republic of Congo was experiencing an active mpox outbreak at the time of travel. ^[1] That context matters enormously. Carrying viral samples — even deactivated ones — out of an active outbreak zone without proper documentation creates exactly the kind of gap in the biosafety chain that regulators are designed to prevent. The scientists were not graduate students unfamiliar with the rules. They were senior NIH researchers whose careers were built around understanding biosafety protocols. The assertion that this was an innocent oversight strains credibility when weighed against that professional background and the volume of material involved — 113 vials is not an accidental pocket item.

The Bigger Problem This Case Exposes

This case lands at an uncomfortable intersection for public trust in federal science agencies. The NIH has faced intense scrutiny in recent years over research practices, institutional transparency, and oversight of dangerous pathogens. A case in which NIH-affiliated scientists allegedly smuggled viral material through a major American airport and lied to federal agents will deepen that skepticism regardless of how the legal proceedings resolve. The charges alone confirm what many Americans have suspected: that some researchers inside government-funded institutions treat biosafety rules as suggestions rather than law. ^[4] That attitude, if proven, is exactly the kind of institutional arrogance that demands accountability — and in this case, federal prosecutors appear determined to provide it.